A Philippine lawmaker slammed the U.S. for its travel advisory for the Asian country, with the politician arguing that the warning is "unfair" coming from "our number one ally." ...

Over 250 Brazilian developers have signed an open letter to Gamescom LATAM, accusing the event of mismanagement. As spotted by Game Developer, the complaints from Game Devs Unidos (GDU) include high ...

The US Department of Health and Human Services said Wednesday that Secretary Robert F. Kennedy Jr. sent a letter urging health care providers and medical boards to update treatment protocols for ...

Kennedy Jr. sent a letter urging health care providers and medical boards to update treatment protocols for youth with gender dysphoria based on a controversial HHS review of scientific literature ...

"The United States should review this advisory. We do not deserve this unfair treatment from our number one ally," he continued. On May 8, the U.S. State Department issued a "Level 2: Exercise ...

“The United States should review this advisory. We do not deserve this unfair treatment from our No 1 ally.” The May 8 advisory, issued by the US State Department, mostly placed the Philippine ...

Finance Minister K.N. Balagopal has accused the Union government of bias in permitting Maharashtra to accept foreign aid for its Chief Minister’s Distress Relief Fund (CMDRF). Responding to the ...

PSTA drivers push for higher pay, claim unfair treatment. BY Angie Angers Pinellas County. UPDATED 3:23 PM ET Feb. 09, 2022 PUBLISHED 7:54 AM ET Feb. 09, 2022 PUBLISHED 7:54 AM EST Feb. 09, 2022.

Billionaire businessman John Magnier has accused a barrister representing the Barne Estate owners of “slaughtering” him and trying to take away his good name. The bloodstock magnate addressed ...

pledging to provide “the best assistance” to Chinese students facing “unfair treatment”. City leader John Lee Ka-chiu weighed in on Thursday after Secretary of State Marco Rubio said the ...

The FDA has slapped Savara with a refuse to file (RTF) letter after the biotech in March applied for approval of molgramostim in the rare disease autoimmune pulmonary alveolar proteinosis (aPAP).